Rankings
▼
Calendar
PRTA
Prothena Corporation plc
$512M
Q2 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$279,000
-99.0% YoY
Gross Profit
-$31M
-11173.1% margin
Operating Income
-$63M
-22605.4% margin
Net Income
-$60M
-21463.1% margin
EPS (Diluted)
$-1.50
QoQ Revenue Growth
+22.9%
Cash Flow
Operating Cash Flow
$58M
Free Cash Flow
$58M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$563M
Total Liabilities
$207M
Stockholders' Equity
$356M
Cash & Equivalents
$486M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$279,000
$27M
-99.0%
Gross Profit
-$31M
-$7M
-331.8%
Operating Income
-$63M
-$18M
-247.8%
Net Income
-$60M
-$18M
-238.3%
← FY 2018
All Quarters
Q3 2018 →
PRTA Q2 2018 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena